DXCM (DexCom) Other Current Payables: $-0 Mil (As of Mar. 2026)


DXCM DexCom Inc DXCM
90 GF Score
Price $68.26
GF Value $103.58
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is DexCom Other Current Payables?

DexCom DXCM -2.46% 90 Other Current Payables is $-0 Mil as of Mar. 2026. GuruFocus rates DXCM with a GF Score™ of 90/100 and a GF Value™ of $103.58 (Significantly Undervalued). The stock has 3 warning signs investors should review.

DexCom's Other Current Payables for the quarter that ended in Mar. 2026 was $-0 Mil.

DexCom's quarterly Other Current Payables stayed the same from Sep. 2025 ($0 Mil) to Dec. 2025 ($0 Mil) but then declined from Dec. 2025 ($0 Mil) to Mar. 2026 ($-0 Mil).

DexCom Other Current Payables Related Terms

DexCom Other Current Payables Historical Data

* Premium members only.

The historical data trend for DexCom's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexCom Other Current Payables Chart

DexCom Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DexCom Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.00
DXCM
90GF Score
DexCom Inc DXCM
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexCom Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $-0 Mil mean?
DexCom (DXCM) has a Other Current Payables of $-0 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on DexCom and its competitors.
Is DexCom's Other Current Payables too high?
DexCom's current Other Current Payables is $-0 Mil. Overall, DexCom has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DexCom's Other Current Payables compare to GEHC and STE?
DexCom's Other Current Payables of $-0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on DexCom and its competitors. DexCom's current Other Current Payables is $-0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexCom stock overvalued right now?
Based on GuruFocus' analysis, DexCom (DXCM) is currently considered Significantly Undervalued. The stock's GF Value™ is $103.58, compared to a current price of $68.26 — trading 34.1% below its estimated fair value. The current Other Current Payables is $-0 Mil. DexCom's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For DexCom (DXCM), the current Other Current Payables is $-0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DexCom (DXCM) Overvalued in 2026?

Based on GuruFocus' analysis, DexCom stock appears to be undervalued. The current stock price of $68.26 is trading 34.1% below its estimated GF Value™ of $103.58. GuruFocus considers DexCom to be Significantly Undervalued.

Key valuation signals for DXCM:

  • Other Current Payables: $-0 Mil
  • GF Value™: $103.58 vs. price of $68.26 (34.1% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the DXCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DexCom Business Description

Address 6340 Sequence Drive, San Diego, CA, USA, 92121
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
90GF Score

Get the complete analysis for DXCM

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$68.26
Price
$103.58
GF Value